SCHEDULE: JPMorgan Chase Boosts Natera Stake to 9.1%

JPMorgan Chase & Co. has disclosed a 9.1% beneficial ownership stake in Natera, Inc., holding over 12.8 million shares as of December 31, 2025.

Summary

• JPMorgan Chase & Co. reported beneficial ownership of 12,825,640 shares of Natera, Inc. common stock.
• This represents 9.1% of Natera, Inc.'s outstanding common stock.
• The filing is an Amendment No. 2 to a Schedule 13G, indicating an update to a previously reported ownership position.
• JPMorgan Chase & Co. holds sole voting power over 11,614,632 shares and shared voting power over 3,670 shares.
• JPMorgan Chase & Co. holds sole dispositive power over 12,812,792 shares and shared dispositive power over 11,783 shares.
• The ownership is held through various subsidiaries, including J.P. Morgan Trust Company of Delaware, J.P. Morgan Securities LLC, and JPMorgan Chase Bank, National Association.
• JPMorgan Chase & Co. certified that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Natera, Inc.

Sentiment

Score: 7

Explanation: The filing indicates a significant and passive institutional investment by JPMorgan Chase & Co. in Natera, Inc., which is generally viewed favorably as a vote of confidence from a major financial entity. However, it is a disclosure of ownership rather than a report on operational or financial performance.

Positives

• Increased institutional ownership by a major financial institution like JPMorgan Chase & Co. can signal confidence in Natera, Inc.'s long-term prospects.
• A significant stake by a reputable entity may attract further institutional investment, potentially enhancing market liquidity and stability.
• The filing indicates a passive investment, not an attempt to influence control, which can be seen as a stable form of institutional support for the company's current management and strategy.

Risks

• While the filing states the investment is passive, a large institutional holder always carries the potential for future influence or changes in investment strategy that could impact the stock.
• The concentration of a significant portion of shares with one entity could lead to volatility if that entity decides to significantly alter its position in the future.

Future Outlook

This filing does not provide forward-looking statements or guidance from Natera, Inc. It solely reflects the beneficial ownership position of JPMorgan Chase & Co. as of the reported date.

Industry Context

Schedule 13G filings are routine disclosures by institutional investors who acquire more than 5% of a company's stock, indicating a passive investment intent. JPMorgan Chase & Co.'s significant stake in Natera, Inc., a company in the diagnostics and genetics sector, reflects ongoing institutional interest in the healthcare and biotechnology industries, particularly in companies with innovative diagnostic platforms.

Stakeholder Impact

• Shareholders: Existing shareholders may view the increased institutional ownership as a positive signal, potentially leading to increased investor confidence and stability in the stock.
• Company Management: Management might interpret this as validation of their strategy and operations, potentially easing future capital market access or strategic partnerships.

Key Dates

Recommendation

The filing indicates a significant, passive institutional stake by JPMorgan Chase & Co. in Natera, Inc. While this is generally a positive signal of confidence, a Schedule 13G filing itself does not provide operational or financial performance data to warrant a 'buy' or 'sell' recommendation. It primarily confirms a large institutional investor's position. Investors should 'hold' and await further operational and financial updates from Natera, Inc. to make a more informed decision, while acknowledging the positive signal of institutional backing.

Keywords

Natera Inc, JPMorgan Chase, Beneficial Ownership, Schedule 13G, Institutional Investment, Common Stock, Healthcare, Biotechnology, Diagnostics